12Dec/12

Older and younger chronic leukemia patients may need different therapy – Medical Xpress

Older and younger chronic leukemia patients may need different therapy
Medical Xpress
“The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown

and more »

12Dec/12

CORRECTING AND REPLACING Gencaro(TM) Cardiovascular Effect on … – MarketWatch (press release)

CORRECTING AND REPLACING Gencaro(TM) Cardiovascular Effect on
MarketWatch (press release)
ARCA biopharma, Inc. (NASDAQ:ABIO) , a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, today announced that the paper “Effect of Bucindolol (Gencaro) on Heart Failure

and more »

12Dec/12

Older and Younger Chronic Leukemia Patients May Need Different Therapy – HealthNewsDigest.com


HealthNewsDigest.com

Older and Younger Chronic Leukemia Patients May Need Different Therapy
HealthNewsDigest.com
“The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown

12Dec/12

Chuck Reynolds

Chuck Reynolds passed away peacefully at UW Hospital in Madison on Thursday, Dec. 6, 2012, with his family beside him. He was a post-heart transplant patient who contracted a fungal pneumonia,…